JASDEEP MIGLANI: Open Payments
NPI 1326014853 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329,057 in 432 payments from 3 companies in 2025. Trend: 2023 $135,729 · 2024 $133,741 · 2025 $329,057
Speaker / faculty: $253,873Travel & lodging: $41,595Consulting: $23,775Food & beverage: $9,608Education: $206
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 177 | $134,585 |
| E.R. Squibb & Sons, L.L.C. | 162 | $102,382 |
| Teva Pharmaceuticals USA, Inc. | 93 | $92,090 |
Products named: COBENFY, UZEDY, LYBALVI, ARISTADA.
Industry payments across VA — which companies pay providers there.
